Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
This study has been terminated.
(Lack of enrollment)
Van Andel Research Institute
Cortice Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
First received: November 28, 2011
Last updated: January 18, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||December 2014|
|Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|